| Structure | Chemical Name | CAS | MF |
|
Recombinant human soluble p55 tumour necrosis factor receptor
|
199685-57-9
|
|
|
Methanol, [[1-(2-pyridinyl)ethylidene]amino]- (9CI)
|
199723-86-9
|
C8H10N2O
|
|
Ethyl cis-1,3,4,4a,5,9b-hexahydro-2H-pyrido[4,3-b]indole-2-carboxylate
|
199725-38-7
|
C14H18N2O2
|
|
CEF3
|
199727-62-3
|
C42H74N10O12
|
|
CEF4
|
199727-68-9
|
C53H93N15O13
|
|
2-Furancarboxylicacid,3,4-dimethyl-,methylester(9CI)
|
199728-18-2
|
C8H10O3
|
|
8-Azabicyclo[3.2.1]octan-6-one,8-(1-methylethyl)-(9CI)
|
199731-27-6
|
C10H17NO
|
|
2-Nitro-1H-imidazole-1-acetic acid 2,3,5,6-tetrafluorophenyl ester
|
199734-70-8
|
C11H5F4N3O4
|
|
3-isobutylisobenzofuran-1(3H)-one
|
199736-94-2
|
C12H14O2
|
|
Paliperidone Palmitate
|
199739-10-1
|
C39H57FN4O4
|
|
Benzoyl chloride, 3-(methoxymethyl)- (9CI)
|
199742-77-3
|
C9H9ClO2
|
|
4-Isopropoxy-3-methylbenzaldehyde
|
199743-06-1
|
C11H14O2
|
|
5-BROMO-2-IODOBENZENEMETHANOL
|
199786-58-8
|
C7H6BrIO
|
|
5-O-(P-CHLOROBENZOYL)-3-C-(2-TRIMETHYLSILYLETHYNYL)-D-RIBOFURANOSE
|
199787-18-3
|
C17H21ClO6Si
|
|
Benzeneacetic acid, alpha-[[1-[(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-2-[(1,1-dimethylethyl)amino]-2-oxoethyl]amino]-, methyl ester, (alphaR)- (9CI)
|
199787-81-0
|
C20H26N4O5
|
|
1-(3,4-DICHLOROPHENYL)-3-METHYL-3-PHENYLUREA
|
199788-67-5
|
C14H12Cl2N2O
|
|
3-METHYL-2-METHYLTHIO-4,7(3H,8H)-PTERIDINEDIONE, SODIUM SALT
|
199789-54-3
|
C8H9N4NaO2S
|
|
TRANS-1-(2-(4-(4-BUTYLCYCLOHEXYL)PHENYL)ETHYNYL)-4-ETHOXYBENZENE
|
199795-20-5
|
C26H32O
|
|
Liguiritigenin-7-O-D-apiosyl-4’-O-D-glucoside
|
199796-12-8
|
C26H30O13
|
|
DHA-paclitaxel
|
199796-52-6
|
C69H81NO15
|
|
2-Diphenyphosphino-2'-hydroxyl-1,1'-binaphthyl
|
199796-91-3
|
C32H23OP
|
|
2(3H)-Oxepinone,6,7-dihydro-4-methyl-7-(1-methylethyl)-(9CI)
|
199797-32-5
|
C10H16O2
|
|
ELOCALCITOL
|
199798-84-0
|
C29H43FO2
|
|
N-(2-Fluoroethyl)-2-(2-nitroimidazol-1-yl)acetamide
|
199800-19-6
|
C7H9FN4O3
|
|
AG-041R
|
199800-49-2
|
C31H36N4O5
|
|
3-CHLORO-2-[(4-METHYLPHENYL)THIO]ANILINE
|
199803-23-1
|
C13H12ClNS
|
|
5-{[2-Chloro-5-(trifluoromethyl)phenyl]-amino}-5-oxopentanoic acid
|
199803-46-8
|
C12H11ClF3NO3
|
|
BIS(2-(4-AZIDOSALICYLAMIDO)ETHYL) DISULF
|
199804-21-2
|
C18H18N8O4S2
|
|
N-HYDROXYSULFOSUCCINIMIDYL-4-AZIDOBENZOATE
|
199804-22-3
|
C11H8N4O7S
|
|
ETHYL 6-TERT-BUTYL-2-METHYLNICOTINATE
|
199806-02-5
|
C9H10N2O
|
|
Cilengitide trifluoroacetate
|
199807-35-7
|
C29H41F3N8O9
|
|
Cilengitide Methanesulfonate
|
199807-38-0
|
C28H44N8O10S
|
|
2-Azabicyclo[2.2.1]hept-5-ene-3-carboxylicacid,methylester,endo-(9CI)
|
199807-77-7
|
C8H11NO2
|
|
2-Propanone, 1-(1-butenylthio)-, (Z)- (9CI)
|
199847-77-3
|
C7H12OS
|
|
3-Furanthiol,2,5-dihydro-5-imino-2-methyl-(9CI)
|
199850-29-8
|
C5H7NOS
|
|
3,6-dichloro-N-(2-chloro-3-pyridinyl)
pyridazine-4-carboxamide
|
199850-43-6
|
C10H5Cl3N4O
|
|
BENZOIC ACID, 2-AMINO-4-CHLORO-5-IODO-, METHYL ESTER
|
199850-56-1
|
C8H7ClINO2
|
|
PD 166793
|
199850-67-4
|
C17H18BrNO4S
|
|
4-CHLORO-2-(TERT-BUTYLAMINO)-5-THIAZOLECARBOXALDEHYDE
|
199851-22-4
|
C8H11ClN2OS
|
|
Isocudraniaxanthone B
|
199851-52-0
|
C19H18O6
|
|
2-Pyrrolidinone,4-ethyl-1-methyl-(9CI)
|
199851-83-7
|
C7H13NO
|
|
4-[(3,5-dimethylphenyl)methyl]-9-ethoxy-3-ethyl-7-thia-1,5-diazabicycl o[4.3.0]nona-3,5-dien-2-one
|
199852-35-2
|
C19H24N2O2S
|
|
7H-Thiazolo[3,2-a]pyrimidin-7-one, 3-(bromomethyl)-6-ethyl-2,3-dihydro -5-(1-naphthalenylmethyl)-
|
199852-50-1
|
C20H19BrN2OS
|
|
Guanidine, (4-methyl-1H-benzimidazol-2-yl)- (9CI)
|
199853-99-1
|
C9H11N5
|
|
O-ACETYLSALICYLHYDROXAMIC ACID
|
199854-00-7
|
C9H9NO4
|
|
2-Methoxy-4-methoxymethoxyphenylboronic acid
|
199858-19-0
|
C9H13BO5
|
|
4-chloro-6-cyclopentylpyrimidin-2-amine
|
199863-89-3
|
C9H12ClN3
|
|
4-METHYL-6-(3-FLUOROPHENYL)PYRIMIDIN-2-AMINE
|
199864-42-1
|
C11H10FN3
|
|
4-(5-CHLORO-2-THIENYL)-6-METHYL-2-PYRIMIDINAMINE
|
199864-44-3
|
C9H8ClN3S
|
|
2-PyriMidinaMine, 4-(4-fluoro-1-naphthalenyl)-6-(1-Methylethyl)-, Monohydrochloride
|
199864-86-3
|
C17H17ClFN3
|
|
4-(4-FLUORO-1-NAPHTHALENYL)-6-(1-METHYLETHYL)-2-PYRIMIDINAMINE HYDROCHLORIDE
|
199864-87-4
|
C17H16FN3
|
|
2-PyriMidinaMine, 4-(4-fluoro-1-naphthalenyl)-6-(1-Methylethyl)-, Maleate
|
199864-88-5
|
C21H20FN3O4
|
|
2-PyriMidinaMine, 4-(1-naphthalenyl)-
|
199865-57-1
|
C14H11N3
|
|
1,4-DIFLUORO-2,5-DIMETHOXYBENZENE
|
199866-90-5
|
C8H8F2O2
|
|
8-METHOXYQUINOLINE-5-CARBOXYLIC ACID
|
199871-63-1
|
C16H11Cl2N3O2
|
|
5-Quinolinecarboxylicacid,8-methoxy-2-methyl-(9CI)
|
199872-12-3
|
C12H11NO3
|
|
8-Methoxy-2-(trifluoroMethyl)quinoline-5-carboxylic acid
|
199872-29-2
|
C12H8F3NO3
|
|
NADA
|
199875-69-9
|
C28H41NO3
|
|
Eicosapentaenoyl Serotonin
|
199875-71-3
|
C30H40N2O2
|
|
|
1,1,1-Trimethyl-N-(trimethylsilyl)silanamine hydrolysis products with silica and 3-(triethoxysilyl)-1-propanamine
|
199876-44-3
|
|
|
FMOC ISOTHIOCYANATE
|
199915-38-3
|
C16H11NO2S
|
|
4-(4-DIETHYLAMINO-PHENYL)-THIAZOL-2-YLAMINE
|
199915-40-7
|
C13H17N3S
|
|
N-METHYL-L-PROLINE MONOHYDRATE 98
|
199917-42-5
|
C6H13NO3
|
|
Bicyclo[1.1.1]pentane, 2,2,4,4,5-pentafluoro- (9CI)
|
199917-55-0
|
C5H3F5
|
|
D-Proline, 3-ethenyl-1-methyl-, methyl ester, (3R)-rel- (9CI)
|
199917-93-6
|
C9H15NO2
|
|
3-Penten-2-one, 5-(2-propynyloxy)-, (E)- (9CI)
|
199918-00-8
|
C8H10O2
|
|
L-Proline, 1-(2-propynyl)- (9CI)
|
199918-49-5
|
C8H11NO2
|
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA ISOPROPYL ESTER
|
199920-18-8
|
C23H40O5
|
|
Benzene, [(1-ethenyl-1-propenyl)oxy]- (9CI)
|
199923-60-9
|
C11H12O
|
|
Z-ORN(BOC)-OH
|
199924-46-4
|
C18H26N2O6
|
|
2H-Pyran-2-carboxylicacid,3,4-dihydro-2,6-dimethyl-(9CI)
|
199924-89-5
|
C8H12O3
|
|
4-AMINO-L-PHENYLALANINE HYDRATE
|
199926-19-7
|
C9H14N2O3
|
|
2-ACRYLAMIDOGLYCOLIC ACID MONOHYDRATE
|
199926-33-5
|
C5H9NO5
|
|
3 5-DIHYDROXY-4-METHYLBENZOIC ACID
|
199926-34-6
|
CH3C6H2(OH)2CO2H1/2H2O
|
|
DIHYDROXYFUMARIC ACID HYDRATE, 98%
|
199926-38-0
|
C4H4O6
|
|
CHELIDAMIC ACID MONOHYDRATE, 98
|
199926-39-1
|
C7H7NO6
|
|
1,4,5,8-NAPHTHALENETETRACARBOXYLIC ACID HYDRATE
|
199926-43-7
|
C14H10O9
|
|
1,4-Diazabicyclo[2.2.2]octan-2-one,3,3,5,5-tetramethyl-(9CI)
|
199926-45-9
|
C10H18N2O
|
|
3-Furancarboxylicacid,2,3-dihydro-,2-propenylester(9CI)
|
199927-44-1
|
C8H10O3
|
|
Benzoic acid, 5-hydroxy-2-methyl-4-nitro- (9CI)
|
199929-14-1
|
C8H7NO5
|
|
3-hydroxy-N-p-tolylpropanamide
|
199929-31-2
|
C10H13NO2
|
|
4,5,6,7-tetrachloro-2-(2-hydroxyphenyl)-1H-isoindole-1,3(2H)-dione
|
199930-15-9
|
C14H5Cl4NO3
|
|
6,12,19,20,25,26-HEXAHYDRO-5,27:13,18:21,24-TRIETHENO-11,7-METHENO-7H-DIBENZO [B,N] [1,5,12,16]TETRAAZACYCLOTRICOSINE-5,13-DIIUM DITRIFLUOROACETATE
|
199934-16-2
|
C38H30F6N4O4
|
|
1-(pyridin-4-ylmethyl)-1,4-diazepane
|
199938-13-1
|
C11H17N3
|
|
N'-(2-CHLOROACETYL)-4-METHYLBENZOHYDRAZIDE
|
199938-21-1
|
C10H11ClN2O2
|
|
N'2-(2-CHLOROACETYL)-4-METHYLTHIOPHENE-2-CARBOHYDRAZIDE
|
199938-54-0
|
C8H9ClN2O2S
|
|
2'-FORMYL-BIPHENYL-4-CARBONITRILE
|
199939-26-9
|
C14H9NO
|
|
(S)-1-N-BOC-PIPERIDINE-2-ETHANOL
|
199942-74-0
|
C12H23NO3
|
|
L-BUTHIONINE SULFOXIDE
|
199982-01-9
|
C8H17NO3S
|
|
4-Butyl-4'-iodobiphenyl
|
199982-02-0
|
C16H17I
|
|
2(BIS-(HYDROXYETHYL)AMINO)-6-(4-METHOXYBENZYLAMINO)-9-ISOPROPYL-PURINE
|
199986-75-9
|
C20H28N6O3
|
|
(2-Amino-4-hydroxy-1,3-thiazol-5-yl)acetic acid
|
199991-61-2
|
C5H6N2O3S
|
|
SCABIOSIDE A (SCABIOSA)
|
199998-33-9
|
C47H76O18
|
|
H-TYR-CYS-TRP-SER-GLN-TYR-LEU-CYS-TYR-OH
|
199999-60-5
|
C58H71N11O15S2
|
|
Deoxynivalenol 3-Glucuronide
|
1000000-13-4
|
C21H28O12
|
|
4,7-bis(5-bromothiophen-2-yl)-5,6-dinitro-2,1,3-benzothiadiazole
|
1000000-27-0
|
C14H4Br2N4O4S3
|
|
(2S)-(6aR,11aR,11bS)-4,4,6a,7,11b-pentaMethyl-2,3,4,4a,5,6,6a,11,11a,11b-decahydro-1H-benzo[a]fluoren-9-yl 2,6-diaMinohexanoate
|
1000010-11-6
|
C28H45ClN2O2
|
|
2-Chloro-3,5-dibromo-4-methylpyridine
|
1000017-92-4
|
C6H4Br2ClN
|
|
|
3,5-DIBROMO-2-CHLORO-4-METHYLPYRIDINE
|
1000017-92-4
|
C6H4Br2ClN
|
|
5-Chloroimidazo[1,2-a]pyridine-2-carboxylic acid
|
1000017-93-5
|
C8H5ClN2O2
|